Small Bone Innovations Receives $12M in Series E Financing
Summary
, an orthopedic company focused on technologies and treatments for the small bones and joints, has received a $12m Series E Preferred Stock investment from, Tokyo, Japan.As stated by Anthony G. Viscogliosi, Chairman & CEO of SBi, this investment will accelerate the worldwide rollout of SBi’s S.T.A.R.® total ankle replacement system by providing capital for inventory and expanding surgeon education and training.In addition and separately, SBi APAC, a joint venture with Khazanah Nasional Berhad and Malaysian Technology Development Corporation Sdn.Bhd., signed agreements with Olympus Terumo Biomaterials Corporation for the exclusive distribution of SBi products in Japan and China.SBi operates facilities in New York, NY, Morrisville, PA, Bourg-en-Bresse, France, Donaueschingen, Germany, and Kuala Lumpur, Malaysia and distributes its products and technologies globally in more than 50 countries.